Rchr
J-GLOBAL ID:201401002314996306   Update date: Feb. 01, 2024

Murayama Toshinori

Murayama Toshinori
Affiliation and department:
Job title: 部長/教授
Research field  (1): Medical equipment testing
Research theme for competitive and other funds  (6):
  • 2019 - 2022 Development of new therapeutoc strategy for high-risk chemotherapy-refractory neuroblastoma
  • 2016 - 2019 Establishment of therapeutic strategy for advanced gastrointestinal cancer with targeted alpha therapy
  • 2013 - 2016 A Comprehensive Research aiming at an Integration of Various Ethical Guidelines involving Medical Research -Protection of Study Participants and Public Welfare-
  • 2009 - 2011 Risk-based protection of participants in un-notified clinical trials No-fault Compensation & Informed Consent-
  • 2007 - 2008 The Consolidation of Ethical Infrastructures Supporting Clinical Trials for the Development of Advanced Medicine Technology
Show all
Papers (106):
  • Hiroshi Wakabayashi, Anri Inaki, Kenichi Yoshimura, Toshinori Murayama, Yasuhito Imai, Tetsuya Higuchi, Megumi Jinguji, Tohru Shiga, Seigo Kinuya. Author Correction: A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma. Scientific Reports. 2022. 12. 1. 1347-1347
  • Rie Kuroda, Hiroshi Wakabayashi, Raita Araki, Anri Inaki, Ryosei Nishimura, Yasuhiro Ikawa, Kenichi Yoshimura, Toshinori Murayama, Yasuhito Imai, Tatsuyoshi Funasaka, et al. Phase I/II clinical trial of high-dose [131I] meta-iodobenzylguanidine therapy for high-risk neuroblastoma preceding single myeloablative chemotherapy and haematopoietic stem cell transplantation. European journal of nuclear medicine and molecular imaging. 2022. 49. 5. 1574-1583
  • Shizuko Takahara, Toshiki I Saito, Yasuhito Imai, Takahiro Kawakami, Toshinori Murayama. A use-case analysis of Clinical Data Interchange Standards Consortium/Study Data Tabulation Model in academia in an investigator-initiated clinical trial. Nagoya journal of medical science. 2022. 84. 1. 120-132
  • Akihiko Takeuchi, Makoto Endo, Akira Kawai, Yoshihiro Nishida, Ryu Terauchi, Akihiko Matsumine, Hisaki Aiba, Tomoki Nakamura, Susumu Tandai, Toshifumi Ozaki, et al. Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: The REALIZE study. Frontiers in oncology. 2022. 12. 900010-900010
  • Yoshio Sakai, Shinya Fukunishi, Masayuki Takamura, Kazunori Kawaguchi, Oto Inoue, Soichiro Usui, Shinichiro Takashima, Akihiro Seki, Akira Asai, Yusuke Tsuchimoto, et al. Clinical trial of autologous adipose tissue-derived regenerative (stem) cells therapy for exploration of its safety and efficacy. Regenerative therapy. 2021. 18. 97-101
more...
MISC (207):
  • 溝上 敦, 稲木 杏吏, 泉 浩二, 村山 敏典, 重原 一慶, 野原 隆弘, 角野 佳史, 若林 大志, 絹谷 清剛. 前立腺がん患者を対象とした68Ga-PSMA-11の第I相試験. 日本癌治療学会学術集会抄録集. 2022. 60回. 優秀O24-4
  • 村山 敏典. また改正?!臨床研究の分類に応じた留意点. 日本整形外科学会雑誌. 2022. 96. 7. 529-541
  • 今井 康人, 杉本 修治, 山崎 章子, 大嶋 三郎, 古川 仭, 村山 敏典, 金子 周一. 人工知能(AI)によるHAT(Health Age Trust)システム構築における介護スタッフの業務効率化向上に関するアンケート調査研究. 日本未病学会雑誌. 2022. 28. 1. 31-42
  • 今井 康人, 杉本 修治, 山崎 章子, 大嶋 三郎, 古川 仭, 村山 敏典, 金子 周一. 人工知能(AI)によるHAT(Health Age Trust)システム構築における介護スタッフの業務効率化向上に関するアンケート調査研究. 日本未病学会雑誌. 2022. 28. 1. 31-42
  • 村山 敏典. また改正?! 臨床研究の分類に応じた留意点. 日本整形外科学会雑誌. 2021. 95. 2. S394-S394
more...
Professional career (1):
  • 京都大学博士(医学) (京都大学)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page